Family planning is a core part of care in Multiple Sclerosis (MS), particularly because many patients are women of reproductive age. This webinar reviews the clinical considerations around conception, pregnancy, postpartum relapse risk, breastfeeding, and treatment selection. It also addresses how disease-modifying therapies can be used before, during, and after pregnancy to support both maternal disease control and informed reproductive decision-making.
Learning Objectives
After this webinar, participants should be able to:
- Explain why family planning should be discussed early in the management of women with Multiple Sclerosis (MS).
- Identify the main clinical considerations before conception, during pregnancy, and in the postpartum period.
- Describe how pregnancy influences relapse risk and how postpartum disease activity can be reduced.
- Recognise when fertility support and assisted reproductive techniques may be relevant in women with MS.
- Discuss the safety and practical use of selected disease-modifying therapies during pregnancy and breastfeeding.
- Apply an individualised, multidisciplinary approach to treatment planning in women with MS who wish to conceive.
Pregnancy and Lactation in Multiple Sclerosis
Please subscribe to watch.
Find out more about the speakers:
Director of the Danish Multiple Sclerosis Registry
Consultant neurologist at department of Neurology, Rigshospitalet
Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid
Funding
This webinar was organized with the financial support of Roche. Roche has not been involved in the elaboration of the presentations.
Media
Details
We value your opinion.
